Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

PHASE3CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Inappropriate ADH SyndromeHyponatremia
Interventions
DRUG

SR121463B

Trial Locations (11)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Unknown

Sanofi-Aventis Administrative Office, Macquarie Park

Sanofi-Aventis Administrative Office, Diegem

Sanofi-Aventis Administrative Office, São Paulo

sanofi-aventis Canada, Laval

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Causeway Bay

Sanofi-Aventis Administrative Office, Budapest

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Geneva

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY